Institute for Experimental Cardiovascular Medicine

The Institute for Experimental Cardiovascular Medicine at the Heart Center of the Freiburg University Medical Center has decided to use a CentraXX solution from KAIROS for its biobank following an extensive selection process. CentraXX will be used to manage the biosamples of the Freiburg Heart Center in a quality-assured and data-protection-compliant manner. After the Center for Chronic Immunodeficiency (CCI), the Institute for Experimental Cardiovascular Medicine is the second research institution on the campus of the Freiburg University Medical Center to commission KAIROS with a CentraXX installation.